FIELD: medicine. SUBSTANCE: method involves determining a number of oxidation-antioxidation blood system indices like lipid hydroperoxides as LHP, blood serum malonic dialdehyde as MDA, general blood serum peroxidation activity as GBSPA, blood serum catalase as C and plasma superoxidasmutase in the initial disease stage. Oxidation-antioxidation coefficient is calculated from a formula OAC (in conventional units)= , where LHPI, MDAI, GPAH, SODI, CI are the values denoting the studied biochemical indices in patients suffering from erysipelas; LHPH, MDAH, GPAI, SODI, CI are the values denoting the same biochemical indices in healthy patients. OAC value being found greater than 2.0 CU, bullous or hemorrhagic erysipelas development progress is predicted to take place in the next day. EFFECT: enhanced accuracy, sensitivity and specificity of prognosis. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING EARLY ERYSIPELAS RECURRENCE CASES | 1999 |
|
RU2144191C1 |
METHOD FOR DETECTING THE MERIT FOR PRESCRIBING EMOXYPIN FOR ERYSIPELAS-SUFFERING PATIENTS | 2003 |
|
RU2232995C1 |
METHOD FOR DETERMINING TOXIC DIPHTHERIA DEVELOPMENT COURSE | 1997 |
|
RU2135998C1 |
METHOD OF DETERMINING INDICATIONS FOR ADMINISTERING EMOXIPIN IN TREATMENT OF TOXIC DIPHTHERIA | 1998 |
|
RU2137128C1 |
METHOD FOR PREDICTION OF HEMORRHAGIC FORMS OF DISEASE DEVELOPING IN PATIENTS, SUFFERING FROM ERYSIPELAS OF LOWER EXTREMITIES | 2015 |
|
RU2601370C1 |
METHOD OF ERYSIPELAS RECIDIVATION PREDICTION | 2006 |
|
RU2332847C2 |
METHOD FOR FORECASTING THE RISK OF ERYSIPELAS DEVELOPMENT | 2018 |
|
RU2683314C1 |
0 |
|
SU1778708A1 | |
METHOD FOR PREDICTING CHRONIC RELAPSING DISEASE COURSE IN PERSONS RECOVERED FROM PRIMARY ERYSIPELAS | 1995 |
|
RU2101701C1 |
METHOD FOR TREATMENT OF THE ERYTHEMATIOUS FORM OF SACRED FIRE | 2016 |
|
RU2649963C1 |
Authors
Dates
2000-04-27—Published
1999-01-19—Filed